Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.59B P/E - EPS this Y -23.90% Ern Qtrly Grth -
Income -136.88M Forward P/E -37.39 EPS next Y 32.40% 50D Avg Chg -6.00%
Sales 356.3M PEG - EPS past 5Y - 200D Avg Chg -6.00%
Dividend N/A Price/Book 6.00 EPS next 5Y - 52W High Chg -26.00%
Recommedations 1.70 Quick Ratio 1.38 Shares Outstanding 56.39M 52W Low Chg 35.00%
Insider Own 4.76% ROA -22.25% Shares Float 53.50M Beta 0.92
Inst Own 94.80% ROE -50.77% Shares Shorted/Prior 2.31M/2.24M Price 29.54
Gross Margin 65.20% Profit Margin -38.42% Avg. Volume 429,374 Target Price 30.13
Oper. Margin -46.68% Earnings Date May 30 Volume 346,108 Change -7.37%
About Phreesia, Inc.

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.

Phreesia, Inc. News
PHR Chatroom

User Image Stock_Titan Posted - 1 day ago

$PHR Phreesia’s Alicia Cowley and Natasha Vega Named to MM+M’s ‘Women to Watch’ for 2024 https://www.stocktitan.net/news/PHR/phreesia-s-alicia-cowley-and-natasha-vega-named-to-mm-m-s-women-to-ii1ffshy94ce.html

User Image Stock_Titan Posted - 04/29/24

$PHR Phreesia Sets Release Date for Fiscal First Quarter 2025 Results https://www.stocktitan.net/news/PHR/phreesia-sets-release-date-for-fiscal-first-quarter-2025-j5qxscw6xeaj.html

User Image insiderbuyingselling Posted - 04/12/24

$PHR new insider selling: 2768 shares. http://insiderbuyingselling.com/?t=PHR

User Image insiderbuyingselling Posted - 04/10/24

$PHR new insider selling: 7178 shares. http://insiderbuyingselling.com/?t=PHR

User Image insiderbuyingselling Posted - 04/10/24

$PHR new insider selling: 10175 shares. http://insiderbuyingselling.com/?t=PHR

User Image insiderbuyingselling Posted - 04/10/24

$PHR new insider selling: 12043 shares. http://insiderbuyingselling.com/?t=PHR

User Image Stock_Titan Posted - 03/19/24

$PHR Phreesia Announces Jack Callahan as New Chief Technology Officer https://www.stocktitan.net/news/PHR/phreesia-announces-jack-callahan-as-new-chief-technology-t0jpw7vrdan3.html

User Image anachartanalyst Posted - 03/18/24

https://anachart.com/market-update/march-18th-2024/ $ULTA $PHR $DKS

User Image Oscaruria Posted - 03/14/24

$PHR $30 soon

User Image Poptrts52 Posted - 03/14/24

$PHR Is this halted?

User Image DonCorleone77 Posted - 03/14/24

$PHR Phreesia backs FY25 revenue view $424M-$434M, consensus $428.12M Narrows FY25 adjusted EBITDA view to $12M-$20M from $10M-$20M.

User Image epsguid Posted - 03/14/24

$PHR reported a loss of $0.56, consensus was ($0.58), Earnings Whisper was ($0.52) via @eWhispers #whispermiss http://eps.sh/d/phr

User Image DonCorleone77 Posted - 03/14/24

$PHR Phreesia reports Q4 EPS (56c), consensus (26c) Reports Q4 revenue $95M, consensus $93.53M. "Phreesia ended fiscal year 2024 with strong momentum going into fiscal 2025. We facilitated more than 150 million patient visits in fiscal 2024, or more than one in ten patient visits across the U.S. We are confident that our solutions and our team position us for continued growth and a return to profitability," said CEO and Co-Founder Chaim Indig.

User Image Stock_Titan Posted - 03/14/24

$PHR Phreesia Announces Fourth Quarter Fiscal 2024 Results https://www.stocktitan.net/news/PHR/phreesia-announces-fourth-quarter-fiscal-2024-7lzc9d9bjwjn.html

User Image StockInvest_us Posted - 03/14/24

Signal alert: $PHR - Oversold Trend Short (Undervalued) https://stockinvest.us/l/5qHUYl6OTN

User Image Stock_Titan Posted - 02/27/24

$PHR Phreesia’s Hilary Hatch Again Named to the 2024-2025 NQF Leadership Consortium https://www.stocktitan.net/news/PHR/phreesia-s-hilary-hatch-again-named-to-the-2024-2025-nqf-leadership-v5xverq2wk0z.html

User Image Stock_Titan Posted - 02/20/24

$PHR New Data Shows That Engaging Patients with Relevant Cancer-Prevention Information During Check-In Increases Screening Rates https://www.stocktitan.net/news/PHR/new-data-shows-that-engaging-patients-with-relevant-cancer-3o3wivz7vj12.html

User Image Stock_Titan Posted - 02/05/24

$PHR Phreesia Sets Release Date for Fiscal Fourth Quarter 2024 Results https://www.stocktitan.net/news/PHR/phreesia-sets-release-date-for-fiscal-fourth-quarter-2024-rr6tb3av97a2.html

User Image StockInvest_us Posted - 01/22/24

Signal alert: $PHR - Overbought Trend Short (Overvalued) https://stockinvest.us/l/wY0yAyx3ca

User Image cctranscripts Posted - 01/22/24

Report of proposed sale of securities https://www.conferencecalltranscripts.org/summary/?id=12884715 $PHR

User Image tickeron Posted - 01/22/24

$PHR 7 Insiders at Phreesia sold 192,805 shares last week for $4.7M https://srnk.us/go/4975395

User Image tickeron Posted - 01/19/24

If you’re trading this week, Read This! $PHR RSI Indicator left the overbought zone. View odds of downtrend. https://srnk.us/go/4973003

User Image MarketBeatInsiderTrades Posted - 01/18/24

Phreesia CEO Chaim Indig Sells $88,036.30 in $PHR www.marketbeat.com/stocks/NYSE/PHR/insider-trades/

User Image MarketBeatInsiderTrades Posted - 01/18/24

Phreesia COO Evan Roberts Sells $55,163.85 in $PHR www.marketbeat.com/stocks/NYSE/PHR/insider-trades/

User Image MarketBeatInsiderTrades Posted - 01/18/24

Phreesia General Counsel Allison Hoffman Sells $32,307.80 in $PHR www.marketbeat.com/stocks/NYSE/PHR/insider-trades/

User Image MarketBeatInsiderTrades Posted - 01/18/24

Phreesia SVP Amy Beth Vanduyn Sells $18,117.90 in $PHR www.marketbeat.com/stocks/NYSE/PHR/insider-trades/

User Image MarketBeatInsiderTrades Posted - 01/18/24

Phreesia CFO Balaji Gandhi Sells $22,880.60 in $PHR www.marketbeat.com/stocks/NYSE/PHR/insider-trades/

User Image risenhoover Posted - 01/18/24

Insider Amy Beth VanDuyn reports selling 10,951 shares of $PHR for a total cost of $264,468.48 https://fintel.io/n/us/phr/vanduyn-amy-beth?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=insider

User Image risenhoover Posted - 01/18/24

Insider Balaji Gandhi reports selling 10,124 shares of $PHR for a total cost of $244,602.15 https://fintel.io/n/us/phr/gandhi-balaji?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=insider

User Image risenhoover Posted - 01/18/24

Insider Evan Roberts reports selling 43,328 shares of $PHR for a total cost of $1,046,093.19 https://fintel.io/n/us/phr/roberts-evan?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=insider

Analyst Ratings
Stephens & Co. Overweight Mar 22, 24
RBC Capital Sector Perform Mar 21, 24
JMP Securities Market Outperform Mar 21, 24
Baird Outperform Mar 18, 24
Needham Buy Mar 15, 24
RBC Capital Sector Perform Mar 15, 24
Raymond James Outperform Mar 15, 24
JMP Securities Market Outperform Mar 15, 24
DA Davidson Neutral Mar 15, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Gunzburg Janet Principal Accounting.. Principal Accounting Officer Jan 12 Sell 25.05 533 13,352 40,046 02/02/24
Gandhi Balaji Chief Financial Offi.. Chief Financial Officer Jan 16 Sell 24.33 10,124 246,317 97,534 01/18/24
VanDuyn Amy Beth SVP, Human Resources SVP, Human Resources Jan 16 Sell 24.33 10,951 266,438 119,695 01/18/24
Hoffman Allison C General Counsel & Se.. General Counsel & Secretary Jan 16 Sell 24.33 8,921 217,048 136,859 01/18/24
Roberts Evan Chief Operating Offi.. Chief Operating Officer Jan 16 Sell 24.33 43,328 1,054,170 754,532 01/18/24
Indig Chaim Chief Executive Offi.. Chief Executive Officer Jan 16 Sell 24.33 67,517 1,642,689 1,216,479 01/18/24
Davidoff Michael J. SVP, Payer Business SVP, Payer Business Oct 16 Sell 16.609 1,198 19,898 92,378 10/17/23
Gandhi Balaji Chief Financial Offi.. Chief Financial Officer Oct 16 Sell 16.609 861 14,300 85,658 10/17/23
VanDuyn Amy Beth SVP, Human Resources SVP, Human Resources Oct 16 Sell 16.609 665 11,045 118,146 10/17/23
Hoffman Allison C General Counsel & Se.. General Counsel & Secretary Oct 16 Sell 16.609 1,297 21,542 115,025 10/17/23
Roberts Evan Chief Operating Offi.. Chief Operating Officer Oct 16 Sell 16.609 1,971 32,736 745,860 10/17/23
Linetsky David SVP, Life Sciences SVP, Life Sciences Oct 16 Sell 16.609 2,078 34,514 215,036 10/17/23
Indig Chaim Chief Executive Offi.. Chief Executive Officer Oct 16 Sell 16.609 3,295 54,727 1,241,996 10/17/23
Roberts Evan Chief Operating Offi.. Chief Operating Officer Sep 12 Sell 20.75 3,907 81,070 747,831 09/14/23
Hoffman Allison C General Counsel & Se.. General Counsel & Secretary Sep 12 Sell 20.56 5,466 112,381 116,322 09/14/23
VanDuyn Amy Beth SVP, Human Resources SVP, Human Resources Sep 12 Sell 20.56 3,826 78,663 118,811 09/14/23
Gunzburg Janet Principal Accounting.. Principal Accounting Officer Sep 12 Sell 20.75 934 19,380 41,120 09/14/23
Gandhi Balaji Chief Financial Offi.. Chief Financial Officer Sep 12 Sell 20.75 3,957 82,108 86,519 09/14/23
Davidoff Michael J. SVP, Payer Business SVP, Payer Business Sep 12 Sell 20.56 6,559 134,853 93,576 09/14/23
Indig Chaim Chief Executive Offi.. Chief Executive Officer Sep 12 Sell 20.75 6,555 136,016 1,245,291 09/14/23
Linetsky David SVP, Life Sciences SVP, Life Sciences Sep 12 Sell 20.75 2,178 45,194 7,962 09/14/23
Linetsky David SVP, Life Sciences SVP, Life Sciences Sep 12 Option 5.82 11,853 68,984 219,173 09/14/23
Davidoff Michael J. SVP, Payer Business SVP, Payer Business Apr 21 Sell 33.13 1,075 35,615 95,773 04/25/23
Davidoff Michael J. SVP, Payer Business SVP, Payer Business Apr 10 Sell 30.91 3,466 107,134 97,971 04/12/23
Rasmussen Randy Chief Financial Offi.. Chief Financial Officer Feb 02 Sell 40.00 4,765 190,600 145,594 02/06/23
VanDuyn Amy Beth SVP, Human Resources SVP, Human Resources Feb 02 Sell 40.00 300 12,000 99,459 02/06/23
Davidoff Michael J. SVP, Payer Business SVP, Payer Business Jan 30 Sell 36.72 31,820 1,168,430 105,484 01/31/23
Davidoff Michael J. SVP, Payer Business SVP, Payer Business Jan 30 Option 6.37 12,090 77,013 137,304 01/31/23
Hoffman Allison C General Counsel & Se.. General Counsel & Secretary Jan 18 Sell 36.0662 649 23,407 129,507 01/20/23
Hoffman Allison C General Counsel & Se.. General Counsel & Secretary Dec 13 Sell 35.2 3,910 137,632 102,262 12/15/22
Linetsky David SVP, Life Sciences SVP, Life Sciences Dec 13 Sell 34.6097 11,377 393,755 185,485 12/15/22
VanDuyn Amy Beth SVP, Human Resources SVP, Human Resources Nov 02 Sell 27.18 19,341 525,688 72,427 11/04/22
Davidoff Michael J. SVP, Payer Business SVP, Payer Business Oct 18 Sell 25.26 1,075 27,154 106,114 10/19/22
Davidoff Michael J. SVP, Payer Business SVP, Payer Business Jul 21 Sell 25.00 1,404 35,100 108,312 07/25/22
Davidoff Michael J. SVP, Payer Business SVP, Payer Business Jun 24 Sell 25.1099 5,046 126,705 110,509 06/28/22
Hoffman Allison C General Counsel & Se.. General Counsel & Secretary May 09 Sell 17.5 3,909 68,408 115,099 05/11/22
Indig Chaim Chief Executive Offi.. Chief Executive Officer Feb 18 Option 6.37 78,106 497,535 1,239,687 02/22/22
Roberts Evan Chief Operating Offi.. Chief Operating Officer Jan 11 Option 0.84 43,750 36,750 646,858 01/12/22
Indig Chaim Chief Executive Offi.. Chief Executive Officer Jan 07 Option 2.03 84,270 171,068 1,127,805 01/11/22
Linetsky David SVP, Life Sciences SVP, Life Sciences Nov 01 Option 4.71 5,451 25,674 145,839 11/02/21
Linetsky David SVP, Life Sciences SVP, Life Sciences Nov 01 Sell 70.83 5,451 386,094 140,388 11/02/21
VanDuyn Amy Beth SVP, Human Resources SVP, Human Resources Oct 21 Option 2.03 9,281 18,840 61,705 11/02/21
VanDuyn Amy Beth SVP, Human Resources SVP, Human Resources Oct 21 Sell 35 10,834 379,190 50,871 11/02/21
Linetsky David SVP, Life Sciences SVP, Life Sciences Oct 15 Option 4.71 5,452 25,679 145,840 10/15/21
Linetsky David SVP, Life Sciences SVP, Life Sciences Oct 15 Sell 65.36 5,452 356,343 140,388 10/15/21
Linetsky David SVP, Life Sciences SVP, Life Sciences Aug 31 Sell 71.89 21,455 1,542,400 140,388 08/31/21
Linetsky David SVP, Life Sciences SVP, Life Sciences Aug 31 Option 2.55 21,455 54,710 161,843 08/31/21
Indig Chaim Chief Executive Offi.. Chief Executive Officer Aug 31 Sell 71.83 112,228 8,061,337 1,248,535 08/31/21
Indig Chaim Chief Executive Offi.. Chief Executive Officer Aug 31 Option 5.82 112,228 653,167 1,303,207 08/31/21
Linetsky David SVP, Life Sciences SVP, Life Sciences Aug 27 Sell 70.05 1,300 91,065 140,388 08/27/21